JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hearse, D. J.
Right arrow Articles by Braimbridge, M. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hearse, D. J.
Right arrow Articles by Braimbridge, M. V.

The Journal of Thoracic and Cardiovascular Surgery, Vol 76, 16-23, Copyright © 1978 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and mannitol in coronary infusates

DJ Hearse, DA Stewart and MV Braimbridge

Cardioplegic protective infusates are designed to induce rapid diastolic arrest and also to reduce or delay the onset of ischemic damage. As this study shows, the use of such infusates can greatly improve postischemic recovery of cardiac function. A number of investigators include glucose, insulin, or mannitol in their infusates in an attempt to increase the amount of protection afforded to the ischemic myocardium. Using an isolated, working rat heart model of cardiopulmonary bypass and ischemic cardiac arrest, we have shown that under certain conditions these additives can be deterimental to tissue protection. The deleterious effects of glucose and mannitol are dose dependent and can be modified by the inclusion of insulin in the infusate. The damaging effects of glucose appear to be both osmotic and metabolic in origin and those of mannitol, purely osmotic. The effects of insulin are complex and may affect a number of cellular processes.


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. T. Dirksen, G. J. Laarman, M. L. Simoons, and D. J.G.M. Duncker
Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies
Cardiovasc Res, June 1, 2007; 74(3): 343 - 355.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. P. Dobson and M. W. Jones
Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation
J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 794 - 805.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Kennergren, V. Mantovani, L. Strindberg, E. Berglin, A. Hamberger, and P. Lonnroth
Myocardial interstitial glucose and lactate before, during, and after cardioplegic heart arrest
Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E788 - E794.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. L. Lazar
The Insulin Cardioplegia Trial
J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 842 - 844.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. L. Lazar, S. Chipkin, G. Philippides, Y. Bao, and C. Apstein
Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations
Ann. Thorac. Surg., July 1, 2000; 70(1): 145 - 150.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Nakamura, H. Kuroda, N. Takemoto, S. Ohgi, and T. Mori
Risk of low calcium and high magnesium in continuous warm hyperkalemic cardioplegia
Ann. Thorac. Surg., October 1, 1999; 68(4): 1295 - 1301.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. Rao, F. Merante, R. D. Weisel, T. Shirai, J. S. Ikonomidis, G. Cohen, L. C. Tumiati, N. Shiono, R.-K. Li, D. A. Mickle, et al.
Insulin stimulates pyruvate dehydrogenase and protects humanventricular cardiomyocytes from simulated ischemia
J. Thorac. Cardiovasc. Surg., September 1, 1998; 116(3): 485 - 489.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
X.-H. Ning, Keith.F. Childs, and S. F. Bolling
Glucose Level and Myocardial Recovery After Warm Arrest
Ann. Thorac. Surg., December 1, 1996; 62(6): 1825 - 1829.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
H. L. Lazar, X. Zhang, S. Rivers, S. Bernard, and R. J. Shemin
Limiting Ischemic Myocardial Damage Using Glucose-Insulin-Potassium Solutions
Ann. Thorac. Surg., August 1, 1995; 60(2): 411 - 416.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1978 by The American Association for Thoracic Surgery.